The predictive value of serum neurofilament light chain levels beyond MRI measures for clinical and radiological disease progression in the earliest stages of multiple sclerosis
The longitudinal zNfL changes were related to lesion activity and subsequent atrophy, even after including MRI measures, and cross-sectional zNfL was related to active disease and predictive of disease progression, but not after taking MRI measures into account.
Abstract
This study investigated the predictive value of neurofilament light chain (NfL) levels beyond MRI measures of disease activity in multiple sclerosis (MS). This study is a retrospective post hoc analysis of the early interferon treatment group of the combined 5-year REFLEX/REFLEXION studies in clinically isolated syndrome. Baseline z-scored NfL (zNfL) and changes in zNfL during the first two years were related to brain atrophy, lesion activity, and clinical progression. This study included 262 patients (61.83% female, mean age 31.68 ± 8.43, median Expanded Disability Status Scale 1.5). Mean zNfL levels were highest at baseline and higher in patients with gadolinium-enhancing lesions or high T2 lesion counts (p < 0.001). Baseline zNfL correlated with higher volumes of T2 lesions at baseline and new/enlarging/shrinking/disappearing lesions in years 1 and 2 (rs = 0.20–0.68, p = 0.002– <0.001), faster subsequent central atrophy (r = 0.16, p = 0.035), and an increased risk of and faster conversion to clinically definite MS (OR = 1.18, p = 0.035; HR = 1.16, p = 0.021). Baseline zNfL was no longer predictive when including baseline MRI variables and demographics. Longitudinal zNfL changes correlated especially with shrinking lesions during year 1 (rs = − 0.42, p < 0.001) and new/enlarging lesions during year 2 (rs = 0.26 and 0.23, p < 0.001). Subsequent global and central atrophy (r = −0.18, p = 0.025; r = 0.20, p = 0.015) were only related to zNfL changes during year 2, even after including baseline MRI variables and demographics. Cross-sectional zNfL was related to active disease and predictive of disease progression, but not after taking MRI measures into account. The longitudinal zNfL changes were related to lesion activity and subsequent atrophy, even after including MRI measures.
Abstract Objectives Serum neurofilament light chain (sNfL) reflects neuroaxonal injury in relapsing-remitting multiple sclerosis (RRMS), but its clinical utility is limited by high interindividual variability and confounders such as renal function. Population-based thresholds may therefore be suboptimal for longitudina...
S. de las Heras Flórez, Gema García de la Rosa, Vicente Martín García et al.· Clinical Chemistry and Labor...· 1 citation
Failure to reduce zNfL levels after 1 year of treatment was associated with subsequent disease activity, even in patients otherwise considered stable, providing complementary information to clinical and MRI-based monitoring.
Victoria Fernández, A. Pappolla, P. Carbonell-Mirabent et al.· Neurology· 1 citation
Initiation of DMTs in RRMS patients was associated with a significant decrease in sNfL levels, suggesting reduced neuroaxonal damage following treatment introduction, and monitoring sNfL may represent a useful non-invasive biomarker of biological treatment response in RRMS patients.
M. Vasić, E. Dinčić· Vojnosanitetski Pregled· 0 citations
In early, minimally disabled MS, higher OCB counts are associated with broader MRI lesion distribution and subtle impairment in verbal learning and memory, suggesting that OCB count reflects intrathecal immune activity that parallels MRI-defined lesion topography and may help identify patients with early radiological a...
Yağmur İnalkaç Gemici, Melike Batum, A. Sarıtas et al.· Neurological Sciences· 0 citations
This exploratory pilot study aimed to evaluate serum levels of neurofilament light chain (NfL), peripherin (PRPH), and glial fibrillary acidic protein (GFAP), and to explore their potential associations with nerve conduction studies (NCS) and nerve ultrasound (NUS) in a Swedish cohort of newly diagnosed patients wi...
S. Arvidsson, I. Anan, M. Olsson et al.· Frontiers in Neurology· 0 citations
Introduction: Neurofilament light chains (NfL) are the marker of neuronal injury utilized in many neurological diseases including anti-NMDARE. Nevertheless, the correlation between serum NfL and disease outcome at 2-year follow-up in anti-NMDARE patients remains undetermined.
Objectives/Aims: We aimed to explore the c...
Oranuch Chuapakdee· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.